Company intelligence
Eurofins Transplant Genomics
Transplant Genomics improves organ transplant outcomes through molecular diagnostic tests.
Biotechnology Research
Framingham, US
40 employees
Founded 2013
2 public signals
About Eurofins Transplant Genomics
Transplant Genomics is committed to improving organ transplant outcomes with noninvasive serial monitoring guided by genomics.
Verified activity
Signals from Eurofins Transplant Genomics
2 published signals
Presence & Recognition
Eurofins Transplant Genomics announced that the Nevada Donor Network filled the Hakkasan nightclub for its Inspire Hope dinner to raise funds and awareness for over 700 Nevadans waiting for an organ transplant.
Reported by Eurofins Transplant Genomics
Products & Services
Eurofins Transplant Genomics introduced Eurofins TRAC Plus ID, a whole genome sequencing platform that analyzes a single sample for two distinct signals, donor-derived cell-free DNA and microbial sequences including viral targets such as TTV.
Reported by Eurofins Transplant Genomics